Woodline Partners LP Gh Research PLC Transaction History
Woodline Partners LP
- $13.5 Billion
- Q4 2024
A detailed history of Woodline Partners LP transactions in Gh Research PLC stock. As of the latest transaction made, Woodline Partners LP holds 78,949 shares of GHRS stock, worth $987,651. This represents 0.0% of its overall portfolio holdings.
Number of Shares
78,949
Previous 37,238
112.01%
Holding current value
$987,651
Previous $249,000
121.69%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding GHRS
# of Institutions
34Shares Held
28.3MCall Options Held
10.3KPut Options Held
3.7K-
Bvf Inc San Francisco, CA10.4MShares$130 Million2.72% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.69MShares$83.7 Million0.76% of portfolio
-
Lynx1 Capital Management LP San Juan, PR4.86MShares$60.8 Million13.21% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$41.6 Million0.38% of portfolio
-
Verition Fund Management LLC Greenwich, CT918KShares$11.5 Million0.03% of portfolio
About GH Research PLC
- Ticker GHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,020,800
- Market Cap $651M
- Description
- GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...